TrialPath
Recruiting

Meditative Neurofeedback for Depression

NCT06675240 · University of California, San Diego
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
The goal of this study is to test whether a 5-session meditative neurofeedback intervention significantly alleviates depressive symptoms as well as improves secondary outcomes of rumination and mindfulness.
Eligibility criteria
Inclusion Criteria: * moderate depression per PHQ9 symptom ratings Exclusion Criteria: * active substance abuse/dependence * psychotic disorders * bipolar disorder * displaying acutely suicidal behaviors
Study design
Enrollment target: 60 participants
Allocation: randomized
Masking: triple
Age groups: adult, older_adult
Timeline
Starts: 2024-11-15
Estimated completion: 2027-11-15
Last updated: 2026-10-09
Interventions
Behavioral: MediNFBehavioral: ShamMediNF
Primary outcomes
  • • Change in FCz-FC4 alpha band coherence (iCoh) (8 weeks)
Sponsor
University of California, San Diego · other
Contacts & investigators
ContactJyoti Mishra, PhD · contact · braine@ucsd.edu · 858-621-1517
All locations (1)
University of California San DiegoRecruiting
La Jolla, California, United States
Meditative Neurofeedback for Depression · TrialPath